128 related articles for article (PubMed ID: 2762658)
1. [Platelet aggregation inhibitory therapy in chronic arterial occlusive disease of the lower limbs: results of short-term clinico-instrumental study with indobufen].
Landini G; Poggiali C; Calacoci S; Marino N; Rosselli A
Recenti Prog Med; 1989 Apr; 80(4):204-7. PubMed ID: 2762658
[TBL] [Abstract][Full Text] [Related]
2. [Heparan sulphate in association with indobufen in the treatment of chronic peripheral obliterative arteriopathy of the lower extremities. Controlled clinical trial].
Rossini A; Tascino C; Costa F
Minerva Cardioangiol; 1998 Nov; 46(11):457-69. PubMed ID: 10207294
[TBL] [Abstract][Full Text] [Related]
3. [Prostacyclin and pentoxifylline in the treatment of patients with inoperable occlusions of the peripheral arteries of the lower extremities].
Maksimović ZV
Srp Arh Celok Lek; 1999; 127(7-8):249-53. PubMed ID: 10624398
[TBL] [Abstract][Full Text] [Related]
4. [Clinico-hematological evaluation of 57 patients undergoing antiaggregant treatment with indobufen].
Andriani A; Mosiello G; Chiappetta MG; Gregori G; Rinaldi P
Recenti Prog Med; 1990 Jan; 81(1):49-53. PubMed ID: 2236828
[TBL] [Abstract][Full Text] [Related]
5. [The clinico-instrumental evaluation of the efficacy of picotamide in treating chronic obstructive arteriopathies of the lower extremities].
Canonico V; Ammaturo V; Guarini P; Tedeschi C; Nunziata G; Nappi A; Forgione L; Rengo F
Minerva Cardioangiol; 1991 Mar; 39(3):75-80. PubMed ID: 1881558
[TBL] [Abstract][Full Text] [Related]
6. Indobufen versus dipyridamole plus aspirin in the treatment of patients with peripheral atherosclerotic disease.
Fabris F; Steffan A; Randi ML; Avruscio GP; Cordiano I; Girolami A
J Med; 1992; 23(2):81-92. PubMed ID: 1512524
[TBL] [Abstract][Full Text] [Related]
7. [Chronic treatment of vascular diseases with indobufen].
Belcaro G; Errichi BM; Laurora G; Marinucci R; Cesarone MR; De Cenzo A
Minerva Cardioangiol; 1989 May; 37(5):241-50. PubMed ID: 2779803
[TBL] [Abstract][Full Text] [Related]
8. Influence of indobufen on occlusion of arteriovenous fistulas and some platelet activity in intermittent peritoneal dialysis patients.
Dmoszyńska A; Janicki K; Janicka L; Przesmycki K; Sokołowska B; Walter-Croneck A
Pol J Pharmacol; 1996; 48(3):327-9. PubMed ID: 9112671
[TBL] [Abstract][Full Text] [Related]
9. [Treatment with indobufen of platelet hyperaggregation in a group of patients with vascular diseases].
Barbieri U; Cappelli S; Zaniol P; Righi A; Artusi P; Scorrano M
Minerva Med; 1991; 82(1-2):63-7. PubMed ID: 2000177
[TBL] [Abstract][Full Text] [Related]
10. Double-blind, controlled, multicenter study of indobufen versus placebo in patients with intermittent claudication.
Tönnesen KH; Albuquerque P; Baitsch G; Gomez Alonso A; Ibanez F; Kester RC; Leveson S; Poredos P
Int Angiol; 1993 Dec; 12(4):371-7. PubMed ID: 8207316
[TBL] [Abstract][Full Text] [Related]
11. [Effect of treatment with indobufen on blood viscosity indices and exercise tolerance in patients with coronary disease].
Rdzanek H; Kochmański M; Zochowski RJ
Wiad Lek; 1993 Apr; 46(7-8):245-9. PubMed ID: 8249409
[TBL] [Abstract][Full Text] [Related]
12. [Effects of physical exercise and indobufen in patients with intermittent claudication. Results after a 2-year follow-up].
Binaghi F; Fronteddu PF; Carboni MR; Onnis A; Astara C
Minerva Cardioangiol; 1991 Jun; 39(6):227-31. PubMed ID: 1961441
[TBL] [Abstract][Full Text] [Related]
13. [Critical ischemia in elderly patients. Evaluation of the effect of two different methods of Iloprost therapy on the efficacy, tolerance, modification of quality of life and self-sufficiency].
Cappelli R; Bicchi M; Arrigucci S; Boschi S; Guerrini M; Forconi S
Minerva Cardioangiol; 1999 Mar; 47(3):81-8. PubMed ID: 10389449
[TBL] [Abstract][Full Text] [Related]
14. [The effect of indobufen on aortocoronary bypass patency after 1 week and after 1 year].
Rohn V; Pirk J; Mach T
Cor Vasa; 1993; 35(4):162-4. PubMed ID: 8403942
[TBL] [Abstract][Full Text] [Related]
15. [Intravenous pentoxifylline in Fontaine stage II and III peripheral arterial diseases].
Giansante C; Di Chiara A; Fiotti N; Mauri F; Sorrentino A; Spanghero M; Tomasin L; Calabrese S
Clin Ter; 1990 Sep; 134(5):301-5. PubMed ID: 2149312
[TBL] [Abstract][Full Text] [Related]
16. [Ticlid: clinical effectiveness and significance in combined conservative treatment of chronic obliterating diseases of lower limb arteries].
Koskin VM; Bogdanets LI
Ter Arkh; 1998; 70(9):89-91. PubMed ID: 9821239
[No Abstract] [Full Text] [Related]
17. [Survey on adherence to hygiene and dietary rules in patients with arterial occlusive disease].
Aligne C; Mosnier M; Mistretta F; Larguier JS
J Mal Vasc; 2000 Jun; 25(3):187-94. PubMed ID: 10906634
[TBL] [Abstract][Full Text] [Related]
18. Reduction by indobufen of neutrophil activation in peripheral arterial occlusive disease.
Chello M; Mastroroberto P; Celi V; Romano F; Marchese AR; Colonna A
J Cardiovasc Pharmacol; 1996 Mar; 27(3):417-23. PubMed ID: 8907804
[TBL] [Abstract][Full Text] [Related]
19. Indobufen versus placebo in the prevention of restenosis after carotid endarterectomy: a double-blind pilot study.
Pratesi C; Pulli R; Milanesi G; Lavezzari M; Pamparana F; Bertini D
J Int Med Res; 1991; 19(3):202-9. PubMed ID: 1936509
[TBL] [Abstract][Full Text] [Related]
20. A randomized trial comparing ticlopidine hydrochloride with indobufen for the prevention of stroke in high-risk patients (TISS Study). Ticlopidine Indobufen Stroke Study.
Bergamasco B; Benna P; Carolei A; Rasura M; Rudelli G; Fieschi C
Funct Neurol; 1997; 12(1):33-43. PubMed ID: 9127122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
